- In April 2024, Thermo Fisher Scientific Inc. launched an upgraded series of Invitrogen fluorescence-based protein quantification kits, integrating AI-powered image analysis to support high-throughput screening and live-cell imaging. This development is aimed at advancing drug discovery and protein expression analysis in both academic and pharmaceutical labs
- In March 2024, Merck KGaA (Germany) announced a strategic partnership with several European research institutes to develop next-generation fluorescent protein tags with improved photostability and lower cytotoxicity. These innovations are expected to enhance real-time tracking of cellular processes in developmental biology and cancer research
- In March 2024, Bio-Rad Laboratories, Inc. introduced its FluoroStar Multiplex Protein Assay Kits, capable of detecting multiple fluorescent proteins simultaneously in a single well. Designed for use with advanced plate readers, the kits streamline protein expression analysis and are particularly useful in multiplex cytokine profiling and gene expression workflows
- In February 2024, Abcam plc unveiled its latest line of cell imaging kits that use red and cyan fluorescent proteins for precise visualization of cellular compartments. These kits are optimized for high-resolution fluorescence microscopy and are ideal for neuroscience and immunology research applications
- In January 2024, PerkinElmer Inc. expanded its Opera Phenix High-Content Screening System compatibility with new assay kits based on green and yellow fluorescent proteins. These assay kits support phenotypic screening, toxicity profiling, and real-time kinetic studies, helping researchers gain deeper insights into disease mechanisms
